Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study

Journal of Epidemiology and Community Health

Volumn 57, Issue 2, 2003, Pages 134-140

  Lawlor, D A ^a   Bedford, C ^a   Taylor, M ^a   Ebrahim, S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; STATIN;

CARDIOVASCULAR DISEASE; DISEASE PREVALENCE; HEALTH SURVEY; RISK FACTOR; SPATIAL VARIATION;

AGED; AGING; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FEMININITY; GEOGRAPHIC DISTRIBUTION; HEALTH SERVICE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; PERIPHERAL VASCULAR DISEASE; PHYSICAL EXAMINATION; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; SOCIOECONOMICS; TREATMENT OUTCOME; UNITED KINGDOM;

AGED; ANTICHOLESTEREMIC AGENTS; ASPIRIN; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; ENGLAND; FEMALE; HEALTH SURVEYS; HUMANS; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SCOTLAND; SMOKING; WALES;

UNITED KINGDOM;

EID: 0037310332     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.57.2.134     Document Type: Article

References (43)

1. Petersen S, Mockford C, Rayner M. Coronary heart disease statistics. British heart foundation statistics database 1999. London: British Heart Foundation, 1999.
2. Office of National Statistics. Morbidity Statistics. Cause 1997. Series DH2 No 24. London: The Stationery Office, 1998.
3. Rayner M, Petersen S, Moher M, et al. Coronary heart disease statistics: morbidity supplement 2001 edition. London: British Heart Foundation, 2001.
4. Aronow WS. Approach to symptomatic coronary disease in the elderly: TIME to change? Lancet 2001;358:945-6.
5. Morris RW, Whincup PH, Lampe FC, et al. Geographic variation in incidence of coronary heart disease in Britain: the contribution of established risk factors. Heart 2001;86:277-83.
6. Erens B, Primatesta P. Health Survey for England 1998: cardiovascular disease. London: The Stationery Office, 1999.
7. Royal College of General Practitioners, Office of Population Censuses and Surveys, Department of Health. Morbidity Statistics from General Practice, Fourth National Study, 1991-1992. London: HMSO, 1995.
8. Marmot MG, Davey Smith G, Stansfeld S, et al. Health inequalities among British civil servants: the Whitehall II study. Lancet 1991;337:1387-93.
9. Hart CL, Watt GC, Davey Smith G, et al. Pre-existing ischaemic heart disease and ischaemic heart disease mortality in women compared with men. Int J Epidemiol 1997;26:508-15.
10. Hart C, Ecob R, Davey Smith G. People, places and coronary heart disease risk factors: a multilevel analysis of the Scottish Heart Health Study archive. Soc Sci Med 1997;45:893-902.
11. McCarron P, Davey Smith G, Okasha M, et al. Life course exposure and later disease: a follow-up study based on medical examinations carried out in Glasgow University (1948-68). Public Health 1999;113:265-71.
12. Shaper AG, Pocock SJ, Walker M, et al. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ 1981;283:179-86.
13. Shaper AG, Pocock SJ, Walker M, et al. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health 1985;39:197-209.
14. World Health Organisation. Cerebrovascular disease: a clinical and research classification. WHO Offset Publication. WHO: Geneva, 1978.
15. Marmot M, Brunner E. CHD risk among women: Whitehall II and other studies. In: Sharp I, ed. Coronary heart disease: Are women special? London: National Forum for Coronary Heart Disease Prevention, 1994:57-70.
16. Rose G. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962;27:645-58.
17. Warnick GR, Knopp RH, Fitzpatrick V, et al. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 1990;36:15-19.
18. Walker MK, Whincup PH, Shaper AG, et al. Validation of patient recall of doctor diagnosed heart attach and stroke: a postal questionnaire and record review comparison. Am J Epidemiol 1998;148:355-61.
19. Lampe FC, Walker M, Lennon LT, et al. Validity of a self-reported history of doctor-diagnosed angina. J Clin Epidemiol 1999;52:73-81.
20. Stata Corporation. Intercooled Stata 7.0 for Windows. (6.0)., Texas: Stata, 2000.
21. WHO MONICA Project Principle Investigators. The World Health Organisation MONICA project (Monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988;41:105-14.
22. International Society of Hypertension Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999;17:151-83.
23. Ramsay LE, Williams B, Johnston GD, et al. British Hypertension Society guidelines for hypertension management 1999: summary. BMJ 1999;319:630-5.
24. Lawlor DA, Ebrahim S, Davey Smith G. A lifecourse approach to coronary heart disease and stroke. In: Kuh D, Hardy R, eds. Lifecourse influences on women's health. Oxford: Oxford University Press, 2002:86-120.
25. Mckenna CJ, Forfar JC. Was it a heart attack? BMJ 2002;324:377-8.
26. Lawlor DA, Taylor M, Bedford C, et al. Is housework good for health? Levels of physical activity and factors associated with activity in elderly women. Results from the British Women's Heart and Health Study. J Epidemiol Community Health 2002;56:473-8.
27. Keys A. Seven countries: a multivariate analysis of death and coronary heart disease. London: Harvard University Press, 1980.
28. Nebrand C, Svardsudd K, Horte LG, et al. Geographical variation of mortality from cardiovascular diseases. The Project "Myocardial Infarction in mid-Sweden". Eur Heart J 1991;12:4-9.
29. Carstairs V, Morris R. Deprivation: explaining differences in mortality between Scotland and England and Wales. BMJ 1989;299:886-9.
30. Eames M, Ben-Shlomo Y, Marmot MG. Social deprivation and premature mortality: regional comparison across England. BMJ 1993;307:1097-02.
31. Crombie IK, Smith WCS, Tavendale R, et al. Geographical clustering of risk factors and lifestyle for coronary heart disease in the Scottish Heart Health Study. Br Heart J 1990;64:199-203.
32. Kjeldsen SE, Kolloch RE, Leonetti G, et al. Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment. J Hyperten 2000;18:629-42.
33. Perry HM Jr, Davis BR, Price TR, et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 2000;284:465-71.
34. Ebrahim S, Davey Smith G, McCabe C, et al. What role for statins? A review and economic model. Health Technol Assess 1998;3:i-91
35. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
36. Euroaspire I and II group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 2001;357:995-1001.
37. Hippisley-Cox J, Pringle M, Crown N, et al. Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ 2001;322:832-6.
38. Bowling A. Ageism in cardiology. BMJ 1999;319:1353-5.
39. Scottish Intercollegiate Guidelines Network (SIGN). Secondary prevention of coronary heart disease following myocardial infarction. SIGN publication number 41. Edinburgh: SIGN, 2000.
40. Eccles M, Freemantle N, Mason J. North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group. BMJ 1998;316:1303-9.
41. Department of Health. National Service Framework for coronary heart disease. Modern standards and service models. London: Department of Health, 2000.
42. Pyörälä K, De Backer G, Graham I, et al. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994;15:1300-31.
43. Wood D, De Backer G, Faergeman O, et al. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens 1998;16:1407-14.